再鼎医药(09688.HK)授出2.5万份购股权及3.2万股受限制股份单位
Core Viewpoint - The company announced the grant of stock options and restricted stock units as part of its 2024 equity incentive plan, indicating a focus on employee retention and motivation [1] Group 1: Stock Options and Restricted Stock Units - The company granted a total of 25,000 American Depositary Shares (ADS) stock options to one grantee [1] - Additionally, the company awarded a total of 32,150 restricted stock units (RSUs) to seven grantees [1] - The grants are set to take effect on October 1, 2025, Eastern Time [1]